From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking

LA Guindo, M Wagner, R Baltussen, D Rindress… - Cost effectiveness and …, 2012 - Springer
Objectives Resource allocation is a challenging issue faced by health policy decisionmakers
requiring careful consideration of many factors. Objectives of this study were to identify …

Social values in health priority setting: a conceptual framework

S Clark, A Weale - Journal of health organization and management, 2012 - emerald.com
Purpose–It is commonly recognized that the setting of health priorities requires value
judgements and that these judgements are social. Justifying social value judgements is an …

Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement

PA Deverka, DC Lavallee, PJ Desai… - Journal of …, 2012 - becarispublishing.com
Aims: Stakeholder engagement is fundamental to comparative effectiveness research
(CER), but lacks consistent terminology. This paper aims to define stakeholder engagement …

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada

FM Clement, A Harris, JJ Li, K Yong, KM Lee… - Jama, 2009 - jamanetwork.com
Context National public insurance for drugs is often based on evidence of comparative
effectiveness and cost-effectiveness. This study describes how that evidence has been used …

EBM, HTA, and CER: clearing the confusion

BR Luce, M Drummond, B Jönsson… - The Milbank …, 2010 - Wiley Online Library
Context: The terms evidence‐based medicine (EBM), health technology assessment (HTA),
comparative effectiveness research (CER), and other related terms lack clarity and so could …

[图书][B] Why isn't government policy more preventive?

P Cairney, E St Denny - 2020 - books.google.com
If'prevention is better than cure', why isn't policy more preventive? Policymakers only have
the ability to pay attention to, and influence, a tiny proportion of their responsibilities, and …

Generating comparative evidence on new drugs and devices before approval

H Naci, M Salcher-Konrad, AS Kesselheim, B Wieseler… - The Lancet, 2020 - thelancet.com
Fewer than half of new drugs have data on their comparative benefits and harms against
existing treatment options at the time of regulatory approval in Europe and the USA. Even …

Healthcare systems in comparative perspective: classification, convergence, institutions, inequalities, and five missed turns

J Beckfield, S Olafsdottir… - Annual review of …, 2013 - annualreviews.org
This article reviews and evaluates recent comparative social science scholarship on
healthcare systems. We focus on four of the strongest themes in current research:(a) the …

[PDF][PDF] Clinical practice variation.

PJ Kennedy, CM Leathley, CF Hughes - Medical Journal of Australia, 2010 - mja.com.au
Clinical practice variation Page 1 MJA • Volume 193 Number 8 • 18 October 2010 S97 USING
WHAT WE GATHER — INFORMATION FOR IMPROVED CARE The Medical Journal of …

Top-down and bottom-up approaches to health care quality: the impacts of regulation and report cards

DB Mukamel, SF Haeder… - Annual review of public …, 2014 - annualreviews.org
The high cost of the US health care system does not buy uniformly high quality of care.
Concern about low quality has prompted two major types of public policy responses …